Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
about
Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case studyCost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.Systematic review of the economic value of diarrheal vaccinesPneumonia prevention: Cost-effectiveness analyses of two vaccines among refugee children aged under two years, Haemophilus influenzae type b-containing and pneumococcal conjugate vaccines, during a humanitarian emergency, Yida camp, South Sudan.Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, TanzaniaAssessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan children.Measurement and valuation of health providers' time for the management of childhood pneumonia in rural Malawi: an empirical study.Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?Sociocultural determinants of anticipated vaccine acceptance for acute watery diarrhea in early childhood in Katanga Province, Democratic Republic of Congo.A critical literature review of health economic evaluations of rotavirus vaccination.Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in the prevention of rotavirus gastroenteritis in developing countries.Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia.How Are New Vaccines Prioritized in Low-Income Countries? A Case Study of Human Papilloma Virus Vaccine and Pneumococcal Conjugate Vaccine in Uganda.Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India.
P2860
Q28257258-2C800FD7-BE9D-4D03-AE04-17913B7D70D7Q31072142-10C3EF30-6DBD-476A-BBC5-58AE690877C3Q33577996-B51BAF4C-8EB3-4602-A692-0F47DDD5FB80Q33871935-9438D9A1-8FCF-408E-9189-095AC51E3578Q34475547-C076D1BB-0536-4108-AB50-CE2FB72B1A52Q34796940-1D0C35D4-56F8-42B9-B372-7E1BC0D34804Q36087645-1DC2966B-48D3-4ACE-BE13-832B65D957A3Q36187591-669AF8FE-5DA4-462C-8480-7DCCA77C4554Q37166084-A86A325C-1B90-46DC-A18D-924C18B542D7Q37514764-DEBEC724-6BA6-402B-ADCE-16E3395DBBBAQ37944318-4050DF8C-A946-4D9A-A93C-04526D19F9A3Q38046665-BEC98B83-95DF-476B-A9C2-F2DF7EB39704Q39219312-E3F85EF4-3FA3-4B99-85C3-D1728F3FA61BQ45324304-85B1C1CE-DCD1-4FCB-A316-4C9AA394115AQ55126608-3261E72F-1573-4594-9DE3-523CA58DBD6B
P2860
Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
@en
type
label
Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
@en
prefLabel
Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
@en
P2093
P1433
P1476
Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
@en
P2093
Amos Odiit
Annet Kisakye
Diana Kizza
Fiona Braka
Prosper Mugyenyi
P304
P356
10.1016/J.VACCINE.2010.12.122
P407
P577
2011-01-15T00:00:00Z